Autophagy in thyroid cancer: present knowledge and future perspectives.
Thyroid cancer is the most common endocrine malignancy. Despite having a good prognosis in the majority of cases, when the tumor is dedifferentiated it does no longer respond to conventional treatment with radioactive iodine, the prognosis worsens significantly. Treatment options for advanced, dedifferentiated disease are limited and do not cure the disease. Autophagy, a process of self-digestion in which damaged molecules or organelles are degraded and recycled, has emerged as an important player in the pathogenesis of different diseases, including cancer. The role of autophagy in thyroid cancer pathogenesis is not yet elucidated. However, the available data indicate that autophagy is involved in several steps of thyroid tumor initiation and progression as well as in therapy resistance and therefore could be exploited for therapeutic applications. The present review summarizes the most recent data on the role of autophagy in the pathogenesis of thyroid cancer and we will provide a perspective on how this process can be targeted for potential therapeutic approaches and could be further explored in the context of multimodality treatment in cancer and personalized medicine.
Department of Medicine, Division of Endocrinology, Radboud University Nijmegen Medical Center , Nijmegen , Netherlands.
Romana T
RT
Netea-Maier
Department of Medicine, Division of Endocrinology, Radboud University Nijmegen Medical Center , Nijmegen , Netherlands.
Viola
V
Klück
Department of Medicine, Division of Endocrinology, Radboud University Nijmegen Medical Center , Nijmegen , Netherlands.
Theo S
TS
Plantinga
Department of Medicine, Division of Endocrinology, Radboud University Nijmegen Medical Center , Nijmegen , Netherlands.
Johannes W A
JW
Smit
autophagy; carcinoma; pathogenesis; therapy; thyroid